4.6 Article

Rapid Proliferation and Differentiation Impairs the Development of Memory CD8+ T Cells in Early Life

期刊

JOURNAL OF IMMUNOLOGY
卷 193, 期 1, 页码 177-184

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1400553

关键词

-

资金

  1. National Institutes of Health from the National Institute of Child Health and Human Development [R00HD067290]
  2. National Institutes of Health from the National Institute of Allergy and Infectious Disease [R01AI105265, R01AI110613]
  3. National Institutes of Health from National Institute of General Medical Sciences [R01GM105668]
  4. Cornell Center for Vertebrate Genomics
  5. National Science Foundation Graduate Research [2011078441]

向作者/读者索取更多资源

Neonates often generate incomplete immunity against intracellular pathogens, although the mechanism of this defect is poorly understood. An important question is whether the impaired development of memory CD8(+) T cells in neonates is due to an immature priming environment or lymphocyte-intrinsic defects. In this article, we show that neonatal and adult CD8(+) T cells adopted different fates when responding to equal amounts of stimulation in the same host. Whereas adult CD8(+) T cells differentiated into a heterogeneous pool of effector and memory cells, neonatal CD8(+) T cells preferentially gave rise to short-lived effector cells and exhibited a distinct gene expression profile. Surprisingly, impaired neonatal memory formation was not due to a lack of responsiveness, but instead because neonatal CD8(+) T cells expanded more rapidly than adult cells and quickly became terminally differentiated. Collectively, these findings demonstrate that neonatal CD8(+) T cells exhibit an imbalance in effector and memory CD8(+) T cell differentiation, which impairs the formation of memory CD8(+) T cells in early life.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Relating In Vitro Neutralization Level and Protection in the CVnCoV (CUREVAC) Trial.

Deborah Cromer, Arnold Reynaldi, Megan Steain, James A. Triccas, Miles P. Davenport, David S. Khoury

Summary: The vaccine candidate CVnCoV (CUREVAC) exhibited lower efficacy compared to other mRNA vaccines in a recent phase 3 trial, which can be attributed to the dosage used and the presence of SARS-CoV-2 variants. The neutralizing antibody response induced by the vaccine can predict the low efficacy.

CLINICAL INFECTIOUS DISEASES (2022)

Article Immunology

Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design

Jillian S. Y. Lau, Deborah Cromer, Mykola Pinkevych, Sharon R. Lewin, Thomas A. Rasmussen, James H. McMahon, Miles P. Davenport

Summary: This study used mathematical models to explore ways to improve ATI study design to maximize statistical power and minimize risks to participants.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Infectious Diseases

Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice

Arya SheelaNair, Aleksandra S. Romanczuk, Rosemary A. Aogo, Rohit Nemai Haldar, Lianne I. M. Lansink, Deborah Cromer, Yandira G. Salinas, R. Kiplin Guy, James S. McCarthy, Miles P. Davenport, Ashraful Haque, David S. Khoury

Summary: This study compared the effects of different anti-malarial drugs on mice infected with malaria. The results showed that different drugs varied in their ability to reduce parasite count and had different mechanisms of action. This suggests that although the parasite clearance curves may be similar, the drugs have different capacities to inhibit, kill, and clear parasites.

MALARIA JOURNAL (2022)

Article Multidisciplinary Sciences

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Sandile Cele, Laurelle Jackson, David S. Khoury, Khadija Khan, Thandeka Moyo-Gwete, Houriiyah Tegally, James Emmanuel San, Deborah Cromer, Cathrine Scheepers, Daniel G. Amoako, Farina Karim, Mallory Bernstein, Gila Lustig, Derseree Archary, Muneerah Smith, Yashica Ganga, Zesuliwe Jule, Kajal Reedoy, Shi-Hsia Hwa, Jennifer Giandhari, Jonathan M. Blackburn, Bernadett Gosnell, Salim S. Abdool Karim, Willem Hanekom, Anne von Gottberg, Jinal N. Bhiman, Richard J. Lessells, Mahomed-Yunus S. Moosa, Miles P. Davenport, Tulio de Oliveira, Penny L. Moore, Alex Sigal

Summary: The study found that the Omicron variant has reduced neutralizing effectiveness in individuals vaccinated with Pfizer BNT162b2, but those who had previously been infected with SARS-CoV-2 showed better neutralization against Omicron.

NATURE (2022)

Article Immunology

An IL-9-pulmonary macrophage axis defines the allergic lung inflammatory environment

Yongyao Fu, Jocelyn Wang, Baohua Zhou, Abigail Pajulas, Hongyu Gao, Baskar Ramdas, Byunghee Koh, Benjamin J. Ulrich, Shuangshuang Yang, Reuben Kapur, Jean-Christophe Renauld, Sophie Paczesny, Yunlong Liu, Robert M. Tighe, Paula Licona-Limon, Richard A. Flavell, Shogo Takatsuka, Daisuke Kitamura, Robert S. Tepper, Jie Sun, Mark H. Kaplan

Summary: This study reveals that IL-9 mediates proallergic activities in the lungs by targeting lung macrophages. Interstitial macrophages are required for IL-9-dependent allergic responses. Mechanistically, IL-9 affects the function of lung macrophages by inducing Arg1 activity.

SCIENCE IMMUNOLOGY (2022)

Article Dermatology

γδ T Cell.Mediated Wound Healing Is Diminished by Allergic Skin Inflammation

Jocelyn Wang, Abigail Pajulas, Yongyao Fu, Djamilatou Adom, Wenwu Zhang, Andrew S. Nelson, Dan F. Spandau, Mark H. Kaplan

Summary: Atopic dermatitis leads to changes in skin function, including barrier impairment and altered production of antimicrobial peptides. This study found that allergic skin inflammation results in a significant decrease in a specific population of T cells in the skin, which is dependent on IL-4. Furthermore, it was observed that wound healing process is hindered in allergic skin inflammation, but can be rescued by cytokines produced by specific T cells.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Immunology

Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory

Kathleen M. Wragg, Wen Shi Lee, Marios Koutsakos, Hyon-Xhi Tan, Thakshila Amarasena, Arnold Reynaldi, Grace Gare, Penny Konstandopoulos, Kirsty R. Field, Robyn Esterbauer, Helen E. Kent, Miles P. Davenport, Adam K. Wheatley, Stephen J. Kent, Jennifer A. Juno

Summary: Wragg and colleagues tracked clonal populations of spike-specific CD4(+) cT(FH) cells using MHC class II tetramers and TCR beta sequencing in convalescent individuals with COVID-19 or SARS-CoV-2-vaccinated individuals. They found that both infection and vaccination induced CD4(+) T cell responses to the spike protein and that these responses correlated with neutralizing antibodies. Secondary exposure led to the recall of CD4(+) T cells with a transitory CXCR3(+) phenotype and expansion of cT(FH) cells temporarily expressing ICOS, CD38, and PD-1. The study demonstrates that stable pools of cT(FH) and memory CD4(+) T cells established by infection and/or vaccination can be efficiently recalled and may contribute to long-term protection against SARS-CoV-2.

NATURE IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9

Yongyao Fu, Abigail Pajulas, Jocelyn Wang, Baohua Zhou, Anthony Cannon, Cherry Cheuk Lam Cheung, Jilu Zhang, Huaxin Zhou, Amanda Jo Fisher, David T. Omstead, Sabrina Khan, Lei Han, Jean-Christophe Renauld, Sophie Paczesny, Hongyu Gao, Yunlong Liu, Lei Yang, Robert M. Tighe, Paula Licona-Limon, Richard A. Flavell, Shogo Takatsuka, Daisuke Kitamura, Jie Sun, Basar Bilgicer, Catherine R. Sears, Kai Yang, Mark H. Kaplan

Summary: The role of IL-9 in the tumor microenvironment and its effects on macrophages have been investigated. The study shows that IL-9 promotes the expansion of pulmonary macrophages and targeting the IL-9R/arginase 1 axis restricts tumor growth, suggesting that this cytokine pathway could be a potential therapeutic target for lung cancer.

NATURE COMMUNICATIONS (2022)

Editorial Material Cell Biology

Nice and slow make the germinal centers go: measured and escalating antigen delivery enhance durability and quality of humoral immune responses against HIV-1

Hyon-Xhi Tan, Miles P. Davenport, Stephen J. Kent, Adam K. Wheatley

IMMUNOLOGY AND CELL BIOLOGY (2022)

Article Multidisciplinary Sciences

Early microbial exposure shapes adult immunity by altering CD8+T cell development

Cybelle Tabilas, David S. Iu, Ciaran W. P. Daly, Kristel J. Yee Mon, Arnold Reynaldi, Samantha P. Wesnak, Jennifer K. Grenier, Miles P. Davenport, Norah L. Smith, Andrew Grimson, Brian D. Rudd

Summary: Microbial exposure during development can have long-lasting effects on an individual's health, but how early microbial exposure leads to permanent changes in the immune system is still unclear. This study shows that early microbial exposure results in the preferential expansion of specific CD8+ T cell populations, which persist and provide enhanced immune protection against intracellular pathogens. Interestingly, this microbial education occurs during thymic development and involves changes in epigenetic programming.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Biochemistry & Molecular Biology

Predicting the efficacy of variant-modified COVID-19 vaccine boosters

David S. Khoury, Steffen S. Docken, Kanta Subbarao, Stephen J. Kent, Miles P. Davenport, Deborah Cromer

Summary: Booster vaccination is necessary to combat waning immunity and variants of SARS-CoV-2. Data on neutralization titers from multiple sources suggest that using ancestral vaccines can enhance protection against symptomatic and severe disease caused by variant viruses. Variant-modified vaccines may provide additional benefits. This study provides evidence-based guidance for future COVID-19 vaccine regimens.

NATURE MEDICINE (2023)

Article Multidisciplinary Sciences

Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis

Deborah Cromer, Megan Steain, Arnold Reynaldi, Timothy E. Schlub, Shanchita R. Khan, Sarah C. Sasson, Stephen J. Kent, David S. Khoury, Miles P. Davenport

Summary: The study demonstrates a strong correlation between neutralising antibody titres and vaccine effectiveness against symptomatic and severe COVID-19. Predicted neutralising antibody titres are strongly correlated with observed vaccine effectiveness, and the loss of neutralising antibodies over time and to new variants is predictive of observed vaccine protection against severe COVID-19.

NATURE COMMUNICATIONS (2023)

Article Immunology

Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?

Stephen J. Kent, David S. Khoury, Arnold Reynold, Jennifer A. Juno, Adam K. Wheatley, Eva Stadler, E. John Wherry, James Triccas, Sarah C. Sasson, Deborah Cromer, Miles P. Davenport

Summary: Understanding the role of T cells in SARS-CoV-2 infection is crucial for the design of next-generation vaccines. This perspective discusses the challenges in determining the causal relationship between vaccine-induced T cell immunity and protection from COVID-19, and proposes an approach to gather evidence and clarify the role of vaccine-induced T cell memory in protecting against severe COVID-19.

NATURE REVIEWS IMMUNOLOGY (2022)

Article Immunology

Parasite Viability as a Superior Measure of Antimalarial Drug Activity in Humans

Maria Rebelo, Rebecca Pawliw, Jeremy Gower, Lachlan Webb, Hayley Mitchell, Zuleima Pava, Rebecca E. Watts, Miles P. Davenport, James S. McCarthy, David S. Khoury

Summary: This study found that viable parasites in artemisinin-sensitive infections decreased to <0.1% of baseline within 8 hours after artesunate administration, while the total number of circulating parasites measured with quantitative polymerase chain reaction remained unchanged. In artemisinin-resistant infections over the same interval, viable parasites declined to 51.4% of baseline. These results suggest that the in vivo drug activity of artesunate is quicker than previously reported based on parasite clearance half-life.

JOURNAL OF INFECTIOUS DISEASES (2021)

Review Immunology

Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection

Deborah Cromer, Jennifer A. Juno, David Khoury, Arnold Reynaldi, Adam K. Wheatley, Stephen J. Kent, Miles P. Davenport

Summary: The duration of immunity to COVID-19 and the risk of reinfection remain unclear. Immunity is crucial for long-term control of the pandemic, but studies suggest a decline in antibody responses and an increase in documented cases of reinfection with SARS-CoV-2. Understanding memory responses and immune control dynamics is essential for designing vaccines and predicting the future trajectory of the pandemic.

NATURE REVIEWS IMMUNOLOGY (2021)

暂无数据